Prevention of CV outcomes in antihyperglycaemic drug-naïve patients with type 2 diabetes with, or at elevated risk of, ASCVD: to start or not to start with metformin.

Authors :: Sattar N
McGuire DK
Source :: European heart journal [Eur Heart J] 2021 Jul 08; Vol. 42 (26), pp. 2574-2576.
Publication Year :: 2021

Subjects :: Humans
Hypoglycemic Agents therapeutic use
Cardiovascular Diseases
Diabetes Mellitus, Type 2 drug therapy
Metformin therapeutic use
Pharmaceutical Preparations

Full Text Access

Tools